Sign In
Buy NVST
$22.40
-0.540 (-2.35%)
At Close: Jun 03, 2026
NVST Stock Explained for 2026 Growth Drivers and Risks
12:21pm, Wednesday, 03'rd Jun 2026
Envista targets margin gains via its Business System while boosting R&D and buybacks, with a $24 6-12 month target vs $22.94.
Here's Why Envista (NVST) is a Strong Value Stock
10:41am, Tuesday, 02'nd Jun 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Envista Holdings Corp (NVST) Shares Surge 3.1% -- What GF Score of 82 Tells Investors
09:18pm, Wednesday, 20'th May 2026
On May 20, 2026, Envista Holdings Corp (NVST) shares rose 3.1% to a current price of $23.77. This move comes in the context of a 52-week range of $16.41 to $30.
Why Envista (NVST) is a Top Value Stock for the Long-Term
10:41am, Friday, 15'th May 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Americans Are Cutting Spending on Everything Except Healthcare. These 2 Medical Device Stocks Under $30 Are Built to Win
08:57am, Wednesday, 13'th May 2026
With consumer sentiment sitting at 53.3 in March 2026, deep in pessimistic territory, retail investors are hunting for defensive names that can grow even as households tighten budgets.
Envista Q1 Earnings Call Highlights
05:06am, Wednesday, 13'th May 2026
Envista NYSE: NVST reported a strong start to 2026, with management citing broad-based growth across its major dental businesses, margin expansion and continued investment in new products and commerci
Envista (NVST) International Revenue Performance Explored
10:16am, Monday, 11'th May 2026
Explore Envista's (NVST) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Why Envista (NVST) is a Top Growth Stock for the Long-Term
10:46am, Friday, 08'th May 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Envista: Spotlight On Q1 Outperformance And New Growth Drivers
07:16am, Thursday, 07'th May 2026
My existing 'buy' rating for Envista is left unchanged following my evaluation of its results and outlook. NVST's 1Q2026 earnings beat consensus by 15%, thanks to a defensive dental market and the com
Envista Holdings Corporation (NVST) Q1 2026 Earnings Call Transcript
12:31am, Thursday, 07'th May 2026
Envista Holdings Corporation (NVST) Q1 2026 Earnings Call Transcript
Here's What Key Metrics Tell Us About Envista (NVST) Q1 Earnings
08:02pm, Wednesday, 06'th May 2026
The headline numbers for Envista (NVST) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimate
Envista (NVST) Surpasses Q1 Earnings and Revenue Estimates
07:35pm, Wednesday, 06'th May 2026
Envista (NVST) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.24 per share a year ago.
Envista Reports First Quarter 2026 Results
04:05pm, Wednesday, 06'th May 2026
BREA, Calif., May 6, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended April 3, 2026.
Financial Survey: Stagezero Life Sciences (OTCMKTS:SZLSF) and Envista (NYSE:NVST)
02:06am, Monday, 27'th Apr 2026
Stagezero Life Sciences (OTCMKTS:SZLSF - Get Free Report) and Envista (NYSE: NVST - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies ba
Envista Holdings Corporation $NVST Shares Purchased by Cwm LLC
03:58am, Sunday, 26'th Apr 2026
Cwm LLC boosted its stake in Envista Holdings Corporation (NYSE: NVST) by 55.9% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (
